Product Information
BACLOFEN 10 MG/5 ML SOLUTION is a generic product labeled by Advagen Pharma Ltd., priced at $2.0444 per ML under NDC 72888046602. Its NADAC has been published 57 times since Sep 3, 2025.
FDA first approved this application on Dec 6, 2024. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/5mL
Manufacturer
Advagen Pharma Ltd.NDC
72888046602
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BACLOFENApproval Type
Generic (ANDA)
FDA Application
ANDA214445FDA Approved
12/6/2024
TE Code
AA
On Market Since
6/3/2025
Pharmacological Classes
Price Statistics
The NADAC for BACLOFEN 10 MG/5 ML SOLUTION has been published 57 times since Sep 3, 2025, and over the history we have for it it has declined 19.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0444 per ML |
|---|---|
| All-time high | $2.5325 (Sep 10, 2025) |
| All-time low | $2.0444 (Sep 23, 2026) |
| 52-week high | $2.5057 |
| 52-week low | $2.0444 |
| Median price | $2.3755 |
| Average price | $2.3180 |
| Largest weekly change | -9.9% (May 20, 2026) |
| Weeks tracked | 57 |
| Tracking since | Sep 3, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Baclofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid-ergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BACLOFEN 10 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 10 MG/5 ML SOLUTION, manufactured by Advagen Pharma Ltd., is $2.0444 per ML (NDC 72888046602), effective Sep 30, 2026.
How has the price of BACLOFEN 10 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for BACLOFEN 10 MG/5 ML SOLUTION has declined 19.3%. It has been tracked across 57 weekly CMS publications since Sep 3, 2025.
What are the highest and lowest recorded NADAC prices for BACLOFEN 10 MG/5 ML SOLUTION?
Since Sep 3, 2025, the NADAC for BACLOFEN 10 MG/5 ML SOLUTION has ranged from a low of $2.0444 (Sep 23, 2026) to a high of $2.5325 (Sep 10, 2025), with a median of $2.3755 per ML.
Are there cheaper alternatives to BACLOFEN 10 MG/5 ML SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BACLOFEN 10 MG/5 ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures BACLOFEN 10 MG/5 ML SOLUTION?
BACLOFEN 10 MG/5 ML SOLUTION (NDC 72888046602) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.